| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 55123* | 2017 |
| Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin DPPR Group N Engl J Med 346 (6), 393-403, 2002 | 25245* | 2002 |
| 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study DPPR Group Lancet 374 (9702), 1677-86, 2009 | 3532 | 2009 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2228 | 2019 |
| The Diabetes Prevention Program (DPP): description of lifestyle intervention DPPR Group Diabetes Care 25 (12), 2165-2171, 2002 | 2063 | 2002 |
| Diabetes in older adults MS Kirkman, VJ Briscoe, N Clark, H Florez, LB Haas, JB Halter, ES Huang, ... Diabetes care 35 (12), 2650, 2012 | 1806 | 2012 |
| Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes DPPR Group Diabetes care 29 (9), 2102-2107 29 (9), 2102-2107, 2006 | 1628* | 2006 |
| The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial DPPR Group Annals of internal medicine 142 (8), 611-619., 2005 | 1273 | 2005 |
| TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program DPPR Group N Engl J Med 355 (3), 241-250, 2006 | 1126* | 2006 |
| Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions DPPR Group Journal of Clinical Endocrinology & Metabolism 93 (23), 4774-4779, 2008 | 1036 | 2008 |
| The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance DPPR Group Annals of internal medicine 142 (5), 323-332, 2005 | 869 | 2005 |
| Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program DPPR Group Impact of intensive lifestyle and metformin therapy on cardiovascular …, 2005 | 767* | 2005 |
| The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes DPPR Group Diabetes Care 22 (4), 623-634, 1999 | 704 | 1999 |
| Achieving weight and activity goals among diabetes prevention program lifestyle participants DPPR Group Obesity Research 12 (9), 1426-1434, 2004 | 624 | 2004 |
| Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. DPPR Group Diabetes 54 (4), 1150-1156, 2005 | 581 | 2005 |
| Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin DPPR Group Diabetes 54 (8), 2404-2414, 2005 | 571 | 2005 |
| Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study DPPR Group The Lancet 379 (9833), 2243-2251, 2012 | 553 | 2012 |
| Diabetes in older adults: consensus report MS Kirkman, VJ Briscoe, N Clark, H Florez, LB Haas, JB Halter, ES Huang, ... Journal of the American Geriatrics Society 60 (12), 2342, 2012 | 532 | 2012 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 530 | 2019 |
| The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention An intent-to-treat analysis of the DPP/DPPOS DPPR Group Diabetes Care 35 (4), 723-730, 2012 | 510 | 2012 |
Diabetes Prevention Program Researc...An NIDDK Supported Multi-Center TrialVerified email at bsc.gwu.edu
